Clinical Trials on Diabetes type2 in New Zealand

Total 10357 results

Diatranz Otsuka Limited

Completed

Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus

Type 1 Diabetes

New Zealand
Edgar National Centre for Diabetes Research
University of Otago

Unknown

LOADD (Lifestyle Over and Above Drugs in Diabetes) Study

Type 2 Diabetes Mellitus

New Zealand
Insulet Corporation

Completed

Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes (Evolution)

Diabetes Mellitus

New Zealand
North Shore Hospital, New Zealand

Completed

Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese Patients

Obesity | Type 2 Diabetes Mellitus

New Zealand
Christchurch Clinical Studies Trust Ltd
Medtronic

Unknown

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

Type1diabetes

New Zealand
University of Otago
Edgar National Centre for Diabetes Research

Completed

The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management

Obesity | Type 2 Diabetes Mellitus

New Zealand
Karyopharm Therapeutics Inc

Withdrawn

Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients

Diabetic Foot Ulcers

New Zealand
OcuNexus Therapeutics, Inc.

Terminated

The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers

Diabetic Foot Ulcer

New Zealand
Suzhou Alphamab Co., Ltd.
Novotech (Australia) Pty Limited

Recruiting

A Study to Evaluate Effects of KN056 in Healthy Participants

Type 2 Diabetes

New Zealand
Christchurch Hospital

Unknown

How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

Diabetes Mellitus, Type 2

New Zealand
Zhejiang Doer Biologics Co., Ltd.

Recruiting

A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624

Healthy, Obesity, Metabolically

New Zealand
Bispebjerg Hospital

Completed

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study (CutDM)

Type 2 Diabetes

Denmark
University of Sydney
National Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaborators

Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. (FAME 1 EYE)

Diabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes Mellitus

Australia, Hong Kong, New Zealand
Liggins Institute
Novo Nordisk A/S

Completed

Comparison of Vehicle Delivery Depth Using the NovoFine® 5 mm Needle With or Without a Skin Fold and Inserted at Either 45 or 90 Degrees

Diabetes Mellitus

New Zealand
Melbourne Health

Completed

Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes (INITII)

Type 1 Diabetes

Australia, New Zealand
Pfizer

Terminated

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Type 2 Diabetic Nephropathy

United States
Eli Lilly and Company

Completed

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Type 2 Diabetes

India, Mexico, New Zealand, South Africa
University of Auckland, New Zealand

Completed

β-hydroxybutyrate, Glucose Metabolism and Prediabetes (CETUS)

PreDiabetes

New Zealand
Rutgers, The State University of New Jersey

Completed

Fiber Mix and Glycemic Response

Type2 Diabetes Mellitus

United States
Zafgen, Inc.

Completed

Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus | Overweight and Obesity

Australia, New Zealand
Metavention

Completed

COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy

Diabetes | Endocrine, Nutritional and Metabolic Diseases (E00-E89)

New Zealand
NYU Langone Health

Terminated

Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes

Type2 Diabetes

United States
Albany Research Institute, Inc.

Completed

Blueberry Consumption and Type 2 Diabetes

Type2 Diabetes

United States
Yale University
National Center for Advancing Translational Sciences (NCATS)

Withdrawn

Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study

Diabete Type 2

United States
Albert Einstein College of Medicine
Juvenile Diabetes Research Foundation; National Institutes of Health (NIH)

Completed

Reactive Oxygen Species in the Pathogenesis of Diabetic Complications

Type 1 Diabetes

United States
PegBio Co., Ltd.

Completed

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

Type2 Diabetes Mellitus

United States
Results Group LLC
Southern Connecticut State University

Completed

Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics

Diabetic Foot Ulcer | Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus

United States
Pfizer

Terminated

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Type 2 Diabetes Mellitus

United States
Pfizer

Completed

A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients

Type 2 Diabetes Patients

United States
The Deutsche Diabetes Forschungsgesellschaft e.V.
Algiax Pharmaceuticals GmbH

Recruiting

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes

Type2 Diabetes

Germany
Boston Therapeutics
Sugardown Company Limited

Completed

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

Type2 Diabetes Mellitus

United States
Sansum Diabetes Research Institute
Mayo Clinic; Icahn School of Medicine at Mount Sinai; Harvard University

Completed

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy (LOIS-P)

Type 1 Diabetes Mellitus | Pregnancy in Diabetics

United States
Provectus Pharmaceuticals

Completed

PV-10 Chemoablation of Recurrent Breast Carcinoma

Breast Cancer

New Zealand
German Diabetes Center
Yale University

Enrolling by invitation

"The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes"

Type2 Diabetes

Germany
New York Institute of Technology
American Osteopathic Association

Recruiting

Diabetes and Osteopathic Manipulative Medicine (OMM)

Type2 Diabetes Mellitus | Osteopathy in Diseases Classified Elsewhere

United States
Serodus AS

Recruiting

SER150 vs Placebo in Diabetic Kidney Disease

Diabetic Kidney Disease

Australia, New Zealand
vTv Therapeutics

Completed

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

United States
Auckland District Health Board
Novartis; University of Auckland, New Zealand; IGENZ, Ltd., Auckland

Unknown

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC (DILIGENCE-1)

Clear Cell Renal Cell Carcinoma

New Zealand
Winthrop University Hospital

Withdrawn

Differential Characteristics of Neuropathy in Type 2 Diabetics With and Without Lower Extremity Wounds

Type 2 Diabetes | Diabetic Foot Ulcer | Diabetic Neuropathy

United States
Yale University
Harvard University

Completed

Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID) (HY-GRAID)

Type1 Diabetes

United States
ABK Biomedical

Completed

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC

Metastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectable

New Zealand
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type2 Diabetes Mellitus

United States, Japan
HealthCore-NERI
Yale University

Completed

Type 1 Teamwork: A Tool for Parents of Adolescents With Type 1 Diabetes (Type1)

Type1diabetes | Type1 Diabetes Mellitus

United States
Waikato Hospital
Wellington Hospital

Recruiting

Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma

Glioblastoma

New Zealand
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients (T1DM AP)

Type1 Diabetes Mellitus

United States
Global Cell Med

Unknown

Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients

Diabetes Complications | Diabetes Mellitus Progression

Bahamas
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Mechanisms for Restoration of Hypoglycemia Awareness

Type1 Diabetes Mellitus

United States
University of Auckland, New Zealand
Counties Manukau Health; Waikato Hospital; Cancer Trials New Zealand

Active, not recruiting

Optimal Selenium for Bowel Polyps (OSCAR) (OSCAR)

Colorectal Adenoma

New Zealand
Eli Lilly and Company

Completed

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

Diabetic Neuropathies | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Insulin-Dependent

United States, Spain, Hungary, Australia, Belgium, Denmark, Estonia, Germany, Israel

Clinical Trials on Diabetes type2 in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations